Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.
Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS.
Yank V, et al. Among authors: olkin i.
Ann Intern Med. 2011 Apr 19;154(8):529-40. doi: 10.7326/0003-4819-154-8-201104190-00004.
Ann Intern Med. 2011.
PMID: 21502651
Free PMC article.
Review.